HOME >> BIOLOGY >> NEWS
Jefferson scientists propose mechanism to control the body's red blood cell and platelet production

The new work may provide essential background for new therapeutic strategies in red blood cell and platelet disorders

Researchers at Jefferson Medical College have uncovered a potential switch that helps control the manufacture of red blood cells and blood-clotting platelets. By better understanding how the body keeps tight reins on this process, the scientists hope to someday therapeutically control blood cell production.

For our tissues to have the oxygen they crave, we need to have enough circulating red blood cells. Athletes, for example, may artificially increase the number of blood cells using a hormone, erythropoietin, which helps immature red blood cells mature. But at the same time, too many cells can cause sluggish circulation and stroke.

Controlling the amount of the hormone is one way of regulating red blood cell production. But there's another way, called "negative regulation," which involves blocking the growth and differentiation of red cell precursors. By activating the cell's own programmed suicide process, called apoptosis, researchers can halt the excessive production of red blood cells.

Cesare Peschle, M.D., professor of microbiology and immunology at Thomas Jefferson University in Philadelphia, Ruggero De Maria, M.D., and their co-workers at Jefferson's Kimmel Cancer Center and the Istituto Superiore di Sanita in Rome, found evidence that by activating so-called "death receptors" on the surface of immature red blood cells, an important protein called GATA-1 can be turned off. GATA-1 is crucial to the development of immature blood cells.

They report their work September 30 in the journal Nature. A News and Views article accompanies the research publication.

The scientists found that turning on immature red blood cell death receptors triggers caspases, a family of 14 cysteine enzymes that degrade critical cellular proteins, such as GATA-1. This culminates in
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-6300
Thomas Jefferson University
1-Oct-1999


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... ... company, will present results demonstrating that RNA genetic testing (RGT), as a supplement ... study, awarded as a Top Rated poster, is one of 13 presentations at ...
(Date:4/1/2019)... SAN FRANCISCO (PRWEB) , ... April 01, 2019 ... ... entitled “Method and System for Characterizing Skin Related Conditions” by the US Patent ... 21, 2014. The patent is an invention by uBiome collaborators Dr. Zachary ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, ... a path for this task. Despite this uncertainty, several manufacturers have been successful and ... the first part of this webinar, learn how analytical similarity is achieved in biosimilars ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , ... it’s latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... to Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions ...
(Date:3/27/2019)... ... , ... Lachman is sponsoring the event on April 1-4, where they will ... executive team on site will be available to discuss strategies and tactics to support ... year. , Executives from Lachman participating at this year’s conference include Fran Zipp, President ...
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... Bogey was nine years old when ... arthritis in his left hip. These ailments caused Bogey to experience problems with his ... vehicles, up stairs, and onto his special spot on the couch. , His owners, devastated ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, USDM Life ... life science companies to easily comply with FDA 21 CFR Part 11 and EMA ... managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, including ...
Breaking Biology Technology:
Cached News: